<VariationArchive VariationID="6905" VariationName="NM_003002.4(SDHD):c.278_280del (p.Tyr93del)" VariationType="Deletion" Accession="VCV000006905" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2018-12-17" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21944" VariationID="6905">
      <GeneList>
        <Gene Symbol="SDHD" FullName="succinate dehydrogenase complex subunit D" GeneID="6392" HGNC_ID="HGNC:10683" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="112086873" stop="112095794" display_start="112086873" display_stop="112095794" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="111957570" stop="111966517" display_start="111957570" display_stop="111966517" Strand="+" />
          </Location>
          <OMIM>602690</OMIM>
          <Haploinsufficiency last_evaluated="2021-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHD">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_003002.4(SDHD):c.278_280del (p.Tyr93del)</Name>
      <CanonicalSPDI>NC_000011.10:112088973:TATT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="112088974" stop="112088976" display_start="112088974" display_stop="112088976" variantLength="3" positionVCF="112088973" referenceAlleleVCF="CTAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="111959698" stop="111959700" display_start="111959698" display_stop="111959700" variantLength="3" positionVCF="111959697" referenceAlleleVCF="CTAT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>Y93delY</Name>
      </OtherNameList>
      <ProteinChange>Y93del</ProteinChange>
      <ProteinChange>Y54del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.112088975_112088977del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.112088975_112088977del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.111959699_111959701del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.111959699_111959701del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012337.3" sequenceAccession="NG_012337" sequenceVersion="3" change="g.7129_7131del">
            <Expression>NG_012337.3:g.7129_7131del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033145.1" sequenceAccession="NG_033145" sequenceVersion="1" change="g.2823_2825del">
            <Expression>NG_033145.1:g.2823_2825del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276504.2" sequenceAccession="NM_001276504" sequenceVersion="2" change="c.161_163del">
            <Expression>NM_001276504.2:c.161_163del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263433.1" sequenceAccession="NP_001263433" sequenceVersion="1" change="p.Tyr54del">
            <Expression>NP_001263433.1:p.Tyr54del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276506.2" sequenceAccession="NM_001276506" sequenceVersion="2" change="c.278_280del">
            <Expression>NM_001276506.2:c.278_280del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263435.1" sequenceAccession="NP_001263435" sequenceVersion="1" change="p.Tyr93del">
            <Expression>NP_001263435.1:p.Tyr93del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003002.4" sequenceAccession="NM_003002" sequenceVersion="4" change="c.278_280del" MANESelect="true">
            <Expression>NM_003002.4:c.278_280del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002993.1" sequenceAccession="NP_002993" sequenceVersion="1" change="p.Tyr93del">
            <Expression>NP_002993.1:p.Tyr93del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_077060.2" sequenceAccession="NR_077060" sequenceVersion="2" change="n.313_315del">
            <Expression>NR_077060.2:n.313_315del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276503.2" sequenceAccession="NM_001276503" sequenceVersion="2" change="c.169+1002_169+1004del">
            <Expression>NM_001276503.2:c.169+1002_169+1004del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_9" sequenceAccession="LRG_9">
            <Expression>LRG_9:g.7129_7131del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_9t1" sequenceAccession="LRG_9t1">
            <Expression>LRG_9t1:c.278_280del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_9p1" sequenceAccession="LRG_9p1" change="p.Tyr93del">
            <Expression>LRG_9p1:p.Tyr93del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA016628" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602690.0014" DB="OMIM" />
        <XRef Type="rs" ID="121908983" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003002.4(SDHD):c.278_280del (p.Tyr93del) AND Paragangliomas 1" Accession="RCV000007314" Version="8">
        <ClassifiedConditionList TraitSetID="1900">
          <ClassifiedCondition DB="MedGen" ID="C3494181">Paragangliomas 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003002.4(SDHD):c.278_280del (p.Tyr93del) AND Hereditary cancer-predisposing syndrome" Accession="RCV002433446" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-12-17" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11391796</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21822798</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28255624</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29386252</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">37873498</ID>
        </Citation>
        <DescriptionHistory Dated="2024-04-28">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1900" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5731" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Paraganglioma - glomus jugulare</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1</ElementValue>
                <XRef Type="MIM" ID="168000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PGL 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paragangliomas familial 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Paragangliomas 1</ElementValue>
                <XRef ID="Paragangliomas+1/5578" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paragangliomata</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glomus tumors familial 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CBT1</ElementValue>
                <XRef Type="MIM" ID="168000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PPGL1</ElementValue>
                <XRef Type="MIM" ID="168000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL</ElementValue>
                <XRef Type="MIM" ID="168000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PGL1</ElementValue>
                <XRef Type="MIM" ID="168000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7324" />
                <XRef ID="7324" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2009">
                <ID Source="pmc">2668639</ID>
              </Citation>
              <Citation Type="review">
                <ID Source="PubMed">20816580</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <Citation Type="general" Abbrev="NANETS, 2010">
                <ID Source="PubMed">20664475</ID>
                <ID Source="pmc">3419007</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="general" Abbrev="NANETS, 2021">
                <ID Source="PubMed">33939658</ID>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C3494181" DB="MedGen" />
              <XRef ID="MONDO:0008192" DB="MONDO" />
              <XRef Type="MIM" ID="168000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5232302" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8804877|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002748236" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11391796</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21822798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28255624</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29386252</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">37873498</ID>
          </Citation>
          <Comment>The c.278_280delATT pathogenic mutation (also known as p.Y93del) is located in coding exon 3 of the SDHD gene. This pathogenic mutation results from an in-frame ATT deletion at nucleotide positions 278 to 280. This results in the in-frame deletion of a tyrosine at codon 93. This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with SDHD-related disease (Chen H et al. J Cancer Res Clin Oncol, 2017 Jun;143:953-960; Shi C et al. J Endocr Soc, 2023 Aug;7:bvad093; Ambry internal data). Another alteration at the same codon, c.276_278del (p.Y93del), has also been detected in individuals diagnosed with paragangliomas (Badenhop RF et al. Genes Chromosomes Cancer, 2001 Jul;31:255-63; Andrews KA et al. J Med Genet, 2018 06;55:384-394). Based on internal structural analysis, this alteration is more destabilizing to SDHD than several internally pathogenic variants at the same position and nearby (Ambry internal data, Zhou Q et al. Protein Cell, 2011 Jul;2:531-42). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003002.2:c.278_280delATT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27511" SubmissionDate="2019-07-24" DateLastUpdated="2024-05-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602690.0014_PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1" title="SDHD, TYR93DEL_PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1" />
        <ClinVarAccession Accession="SCV000027511" DateUpdated="2024-05-01" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 5 affected members in 2 generations of a family with paragangliomas (PPGL1; 168000), Badenhop et al. (2001) identified a heterozygous 3-bp deletion in exon 3 of the SDHD gene, resulting in the deletion of tyr93. An affected male transmitted paragangliomas to 2 of his 3 children; an affected female had 2 unaffected children, consistent with genomic imprinting.</Attribute>
              <Citation>
                <ID Source="PubMed">11391796</ID>
              </Citation>
              <XRef DB="OMIM" ID="168000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHD" />
          </GeneList>
          <Name>SDHD, TYR93DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">TYR93DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602690.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5232302" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27511" TraitType="Disease" MappingType="Name" MappingValue="PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C3494181" Name="Paragangliomas 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

